| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated ERK: An Emerging Player in miRNA Downregulation
|
Qu, Yiping
|
|
2017
|
|
3 |
p. 163-165
|
artikel
|
| 2 |
Adaptive inhibition of CGAS signaling by TREX1
|
Lira, María Cecilia
|
|
|
|
3 |
p. 177-179
|
artikel
|
| 3 |
Addressing the genetic/nongenetic duality in cancer with systems biology
|
Kulkarni, Prakash
|
|
|
|
3 |
p. 185-187
|
artikel
|
| 4 |
Advisory Board and Contents
|
|
|
|
|
3 |
p. i-ii
|
artikel
|
| 5 |
Advisory Board and Contents
|
|
|
|
|
3 |
p. i
|
artikel
|
| 6 |
Advisory Board and Contents
|
|
|
|
|
3 |
p. i
|
artikel
|
| 7 |
Advisory Board and Contents
|
|
|
|
|
3 |
p. i-ii
|
artikel
|
| 8 |
Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends
|
Hoang, Song My
|
|
|
|
3 |
p. 247-260
|
artikel
|
| 9 |
Amphiregulin in Cancer: New Insights for Translational Medicine
|
Xu, Qixia
|
|
2016
|
|
3 |
p. 111-113
|
artikel
|
| 10 |
Assessing Novel Therapies Based on Late-Stage Efficacy: A Dangerous Concept?
|
Lønning, Per E.
|
|
|
|
3 |
p. 181-185
|
artikel
|
| 11 |
Autoantibodies: Opportunities for Early Cancer Detection
|
Macdonald, Isabel K.
|
|
2017
|
|
3 |
p. 198-213
|
artikel
|
| 12 |
Benefits and opportunities of the transgenic Oncopig cancer model
|
Joshi, Kirtan
|
|
|
|
3 |
p. 182-184
|
artikel
|
| 13 |
Biophysical determinants of cancer organotropism
|
Azubuike, Udochi F.
|
|
|
|
3 |
p. 188-197
|
artikel
|
| 14 |
Born to Kill: NK Cells Go to War against Cancer
|
Wennerberg, Erik
|
|
2019
|
|
3 |
p. 143-145
|
artikel
|
| 15 |
Calmodulin and PI3K Signaling in KRAS Cancers
|
Nussinov, Ruth
|
|
2017
|
|
3 |
p. 214-224
|
artikel
|
| 16 |
Cancer Is Not (Only) a Senescence Problem
|
Thomas, Frédéric
|
|
2018
|
|
3 |
p. 169-172
|
artikel
|
| 17 |
Chromatin Bottlenecks in Cancer
|
Sarthy, Jay F.
|
|
2019
|
|
3 |
p. 183-194
|
artikel
|
| 18 |
Chromatin Structure Profiling Identifies Crucial Regulators of Tumor Maintenance
|
Bonifer, Constanze
|
|
2015
|
|
3 |
p. 157-160
|
artikel
|
| 19 |
Collateral Lethality: A New Therapeutic Strategy in Oncology
|
Muller, Florian L.
|
|
2015
|
|
3 |
p. 161-173
|
artikel
|
| 20 |
Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres
|
Voon, Hsiao P.J.
|
|
2016
|
|
3 |
p. 114-116
|
artikel
|
| 21 |
Cross-dressing of dendritic cells strengthens antitumor immunity
|
Yin, Hongli
|
|
|
|
3 |
p. 159-160
|
artikel
|
| 22 |
CSB: An Emerging Actionable Target for Cancer Therapy
|
Proietti-De-Santis, Luca
|
|
2018
|
|
3 |
p. 172-175
|
artikel
|
| 23 |
Deciphering the Epitranscriptome in Cancer
|
Lian, Hao
|
|
2018
|
|
3 |
p. 207-221
|
artikel
|
| 24 |
Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma
|
Høgdall, Dan
|
|
2018
|
|
3 |
p. 239-255
|
artikel
|
| 25 |
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
|
Rodrigues, João
|
|
|
|
3 |
p. 249-264
|
artikel
|
| 26 |
Editorial Board
|
|
|
|
|
3 |
p. i-ii
|
artikel
|
| 27 |
Editorial Board and Contents
|
|
|
2015
|
|
3 |
p. i
|
artikel
|
| 28 |
Editorial Board and Contents
|
|
|
2016
|
|
3 |
p. i
|
artikel
|
| 29 |
Editorial Board and Contents
|
|
|
2017
|
|
3 |
p. i
|
artikel
|
| 30 |
Editorial Board and Contents
|
|
|
2018
|
|
3 |
p. i
|
artikel
|
| 31 |
Editorial Board and Contents
|
|
|
2019
|
|
3 |
p. i
|
artikel
|
| 32 |
Epigenetic basis and targeting of cancer metastasis
|
Banerjee, Rakesh
|
|
|
|
3 |
p. 226-241
|
artikel
|
| 33 |
Exploring Stem Cell Heterogeneity in Chronic Myeloid Leukemia
|
Munje, Chinmay
|
|
2018
|
|
3 |
p. 167-169
|
artikel
|
| 34 |
Fasting and fasting mimicking diets in cancer prevention and therapy
|
Blaževitš, Olga
|
|
|
|
3 |
p. 212-222
|
artikel
|
| 35 |
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance
|
Bacci, Marina
|
|
|
|
3 |
p. 198-213
|
artikel
|
| 36 |
Fluorescence Sheds Light on DNA Damage, DNA Repair, and Mutations
|
Owiti, Norah A.
|
|
|
|
3 |
p. 240-248
|
artikel
|
| 37 |
Glioblastoma Stem Cells: Driving Resilience through Chaos
|
Prager, Briana C.
|
|
|
|
3 |
p. 223-235
|
artikel
|
| 38 |
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
|
Cluntun , Ahmad A.
|
|
2017
|
|
3 |
p. 169-180
|
artikel
|
| 39 |
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
|
Adashek, Jacob J.
|
|
|
|
3 |
p. 181-191
|
artikel
|
| 40 |
IFN Signaling and ICB Resistance: Time is on Tumor’s Side
|
López-Soto, Alejandro
|
|
2017
|
|
3 |
p. 161-163
|
artikel
|
| 41 |
Immune Checkpoint Inhibition in Prostate Cancer
|
Nicholson, Lowell Thorndike
|
|
|
|
3 |
p. 174-177
|
artikel
|
| 42 |
Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy
|
Petroni, Giulia
|
|
|
|
3 |
p. 179-181
|
artikel
|
| 43 |
Impact of tissue-agnostic approvals for patients with gastrointestinal malignancies
|
Bhamidipati, Deepak
|
|
|
|
3 |
p. 237-249
|
artikel
|
| 44 |
Impact of tissue-agnostic approvals on management of primary brain tumors
|
Ahluwalia, Manmeet S.
|
|
|
|
3 |
p. 256-274
|
artikel
|
| 45 |
In vivo macrophage engineering as novel therapeutic strategy against liver metastasis
|
Laviron, Marie
|
|
|
|
3 |
p. 175-176
|
artikel
|
| 46 |
It’s all about the base: stromal cells are central orchestrators of metastasis
|
Monteran, Lea
|
|
|
|
3 |
p. 208-229
|
artikel
|
| 47 |
Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care
|
Zhu, Xiaoyan
|
|
|
|
3 |
p. 196-207
|
artikel
|
| 48 |
Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy
|
Liu, Yong
|
|
|
|
3 |
p. 226-239
|
artikel
|
| 49 |
Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity
|
Gargalionis, Antonios N.
|
|
2017
|
|
3 |
p. 166-168
|
artikel
|
| 50 |
Metabolic interplay: tumor macrophages and regulatory T cells
|
Vilbois, Stefania
|
|
|
|
3 |
p. 242-255
|
artikel
|
| 51 |
MicroRNA-Based Drugs for Brain Tumors
|
Anthiya, Shubaash
|
|
2018
|
|
3 |
p. 222-238
|
artikel
|
| 52 |
Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities
|
Bakhoum, Samuel F.
|
|
2017
|
|
3 |
p. 225-234
|
artikel
|
| 53 |
Modeling Normal and Disordered Human Hematopoiesis
|
Beer, Philip A.
|
|
2015
|
|
3 |
p. 199-210
|
artikel
|
| 54 |
Modeling Tumor Clonal Evolution for Drug Combinations Design
|
Zhao, Boyang
|
|
2016
|
|
3 |
p. 144-158
|
artikel
|
| 55 |
Modeling tumor plasticity in organoid models of human cancer
|
Christin, John R.
|
|
|
|
3 |
p. 161-163
|
artikel
|
| 56 |
Molecular Discriminators of Racial Disparities in Prostate Cancer
|
Ateeq, Bushra
|
|
2016
|
|
3 |
p. 116-120
|
artikel
|
| 57 |
Mouse Models Shed Light on the SLIT/ROBO Pathway in Pancreatic Development and Cancer
|
Martinelli, Paola
|
|
2019
|
|
3 |
p. 145-148
|
artikel
|
| 58 |
Multicellular modules as clinical diagnostic and therapeutic targets
|
Baertsch, Marc-A.
|
|
|
|
3 |
p. 164-173
|
artikel
|
| 59 |
Neuronal and tumourigenic boundaries of glioblastoma plasticity
|
De Silva, Manam Inushi
|
|
|
|
3 |
p. 223-236
|
artikel
|
| 60 |
New Insights into Oncogenic Transformation: Elevating Antioxidant and Nucleotide Levels Does the Trick
|
Kesavan, Rushendhiran
|
|
|
|
3 |
p. 177-179
|
artikel
|
| 61 |
New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
|
Slade, Daniel J.
|
|
|
|
3 |
p. 185-187
|
artikel
|
| 62 |
Novel Mechanisms of Regulation of miRNAs in CLL
|
Balatti, Veronica
|
|
2016
|
|
3 |
p. 134-143
|
artikel
|
| 63 |
NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis
|
Nagasaka, Misako
|
|
|
|
3 |
p. 242-258
|
artikel
|
| 64 |
On Epigenetic Plasticity and Genome Topology
|
Lazaris, Charalampos
|
|
|
|
3 |
p. 177-180
|
artikel
|
| 65 |
Optical Microscopy and Coherence Tomography of Cancer in Living Subjects
|
Si, Peng
|
|
|
|
3 |
p. 205-222
|
artikel
|
| 66 |
PALB2 Variants: Protein Domains and Cancer Susceptibility
|
Nepomuceno, Thales C.
|
|
|
|
3 |
p. 188-197
|
artikel
|
| 67 |
Plastic persisters: revival stem cells in colorectal cancer
|
Tape, Christopher J.
|
|
|
|
3 |
p. 185-195
|
artikel
|
| 68 |
Polytherapy and Targeted Cancer Drug Resistance
|
Chatterjee, Nilanjana
|
|
2019
|
|
3 |
p. 170-182
|
artikel
|
| 69 |
Potential Use of Shared Frameshift Mutations in ‘Off-the-Shelf’ Neoantigen Vaccines
|
Thol, Kerstin
|
|
|
|
3 |
p. 175-177
|
artikel
|
| 70 |
Preclinical to clinical utility of ROCK inhibitors in cancer
|
Barcelo, Jaume
|
|
|
|
3 |
p. 250-263
|
artikel
|
| 71 |
Premortem Tumor Stress in Radioimmunotherapy
|
Melero, Ignacio
|
|
|
|
3 |
p. 173-174
|
artikel
|
| 72 |
Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?
|
Özdemir, Berna C.
|
|
2017
|
|
3 |
p. 181-197
|
artikel
|
| 73 |
Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks
|
Ivanisenko, Nikita V.
|
|
|
|
3 |
p. 190-209
|
artikel
|
| 74 |
Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All
|
Shah, Bijal
|
|
2018
|
|
3 |
p. 197-206
|
artikel
|
| 75 |
Resisting T cell attack: tumor-cell-intrinsic defense and reparation mechanisms
|
McKenzie, Brienne
|
|
|
|
3 |
p. 198-211
|
artikel
|
| 76 |
Rise of the Machines: Advances in Deep Learning for Cancer Diagnosis
|
Levine, Adrian B.
|
|
2019
|
|
3 |
p. 157-169
|
artikel
|
| 77 |
RNA Sequencing of the Tumor Microenvironment in Precision Cancer Immunotherapy
|
Lau, Denise
|
|
2019
|
|
3 |
p. 149-156
|
artikel
|
| 78 |
Subscription and copyright page
|
|
|
|
|
3 |
p. e1
|
artikel
|
| 79 |
Subscription and copyright page
|
|
|
|
|
3 |
p. e1
|
artikel
|
| 80 |
Subscription and copyright page
|
|
|
|
|
3 |
p. e1
|
artikel
|
| 81 |
Subscription & copyright page
|
|
|
|
|
3 |
p. e1
|
artikel
|
| 82 |
Subscription & copyright page
|
|
|
|
|
3 |
p. e1
|
artikel
|
| 83 |
Sweet dreams: glycosylation controls tumor cell dormancy
|
Bresnahan, Erin
|
|
|
|
3 |
p. 180-181
|
artikel
|
| 84 |
Targeting myeloid cells for cancer immunotherapy: Siglec-7/9/10/15 and their ligands
|
Boelaars, Kelly
|
|
|
|
3 |
p. 230-241
|
artikel
|
| 85 |
Targeting RAS-mutant Cancers: Is ERK the Key?
|
Ryan, Meagan B.
|
|
2015
|
|
3 |
p. 183-198
|
artikel
|
| 86 |
Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
|
Ceelen, Wim
|
|
|
|
3 |
p. 236-246
|
artikel
|
| 87 |
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
|
Xavier, Joao B.
|
|
|
|
3 |
p. 192-204
|
artikel
|
| 88 |
The Dual Role of High Endothelial Venules in Cancer Progression versus Immunity
|
Milutinovic, Stefan
|
|
|
|
3 |
p. 214-225
|
artikel
|
| 89 |
The Evolving Landscape of Brain Metastasis
|
Valiente, Manuel
|
|
2018
|
|
3 |
p. 176-196
|
artikel
|
| 90 |
The Immune Biology of Microsatellite-Unstable Cancer
|
Kloor, Matthias
|
|
2016
|
|
3 |
p. 121-133
|
artikel
|
| 91 |
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies
|
González-Silva, Laura
|
|
|
|
3 |
p. 265
|
artikel
|
| 92 |
Tumor immunology CRISPR screening: present, past, and future
|
Dong, Matthew B.
|
|
|
|
3 |
p. 210-225
|
artikel
|
| 93 |
Undercover Agents: Targeting Tumours with Modified Platelets
|
Hyslop, Stephanie R.
|
|
2017
|
|
3 |
p. 235-246
|
artikel
|
| 94 |
When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers
|
van Vugt, Marcel A.T.M.
|
|
|
|
3 |
p. 174-189
|
artikel
|
| 95 |
Why Does Infection With Some Helminths Cause Cancer?
|
Brindley, Paul J.
|
|
2015
|
|
3 |
p. 174-182
|
artikel
|
Tijdschrift beschrijving